12:00 AM
 | 
Oct 07, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Texas Biotechnology Corp.

(TXBI), Houston, Texas

Business: Cardiovascular

Needham & Co. analyst Mark Monane lowered his rating to "hold"...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >